
Loading, please wait...

Loading, please wait...

Researchers recently identified a fatal case of systemic campylobacteriosis in a wild American crow nestling in San Diego, CA. This significant finding, published in the Journal of Veterinary Diagnostic Investigation, reveals the presence of a novel pathogen, Campylobacter molothri. This bacterium caused severe encephalitis and sepsis in the young bird. Consequently, the case highlights the critical importance of advanced molecular techniques in identifying emerging pathogens that could impact wildlife and public health.
The postmortem examination revealed a markedly underweight chick with no fat stores. Histologic analysis showed lymphocytic vasculitis in the brain and lymphohistiocytic meningoencephalitis. These areas of inflammation were closely associated with myriad argyrophilic, curved bacilli. Furthermore, clinicians observed severe pectoral myositis and evidence of systemic sepsis, including pancarditis and hepatitis.
Using third-generation sequencing and conventional PCR, scientists identified the bacteria as closely related to Campylobacter molothri. This species belongs to the Campylobacter genus, which contains many well-known human pathogens. While C. jejuni typically causes gastroenteritis, this novel finding suggests that some species may induce more severe systemic infections in specific hosts. Therefore, continuous surveillance of wild bird populations remains essential for understanding the evolutionary landscape of these pathogens.
The discovery of a novel Campylobacter species in a common urban bird like the American crow raises questions about zoonotic potential. Historically, wild birds serve as reservoirs for various Campylobacter strains. Although most infections in birds are asymptomatic, this case demonstrates that certain species can cause significant pathology. Monitoring such events helps identify potential threats to both animal and human health before they cross species barriers.
It refers to a severe infection where Campylobacter bacteria spread from the primary site to the bloodstream and multiple organs, such as the brain and heart.
Currently, researchers have identified C. molothri primarily in wild birds. However, many species in the Campylobacter genus are known zoonotic pathogens that cause significant human disease.
Diagnostic pathologists used advanced tools like third-generation sequencing and PCR to pinpoint the bacterial DNA from tissue samples taken during the autopsy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study identifies Campylobacter molothri causing fatal systemic campylobacteriosis and encephalitis in an American crow chick using advanced sequencing....
5 months ago

Discover clinical pitfalls in diagnosing SGLT2 inhibitor ketoacidosis in the ICU. Learn how cardiac surgery and GLP-1 agonist interactions trigger euglycemic DKA and explore management strategies.
Today

A new study reveals that pregnant women with gestational diabetes show altered neural responses to high-fat visual food cues compared to healthy controls. Using visual evoked potentials, researchers found that these early neurophysiological responses correlate with HbA1c levels and metabolic health.
Today

A multi-state Indian study by KMCRI reveals alarming cardiovascular risk markers among healthy adolescents and young adults, including hyperhomocysteinemia and early blood vessel damage.
Today

A 69-year-old male presented with a painless thigh mass, initially suspected as a primary soft tissue tumor. Post-surgical pathology confirmed squamous cell carcinoma. Subsequent FDG PET/CT and EBUS biopsy identified primary lung cancer, proving skeletal muscle metastasis can be the first sign of occult malignancy.
Today

Per-protocol analysis of the PRAGUE-25 trial demonstrates that catheter ablation significantly reduces atrial fibrillation burden, hospitalizations, and emergency visits compared to lifestyle modification plus antiarrhythmic drugs in obese patients.
Today